http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 28 Mar 2025 17:24:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Notice+to+Long-term+Actinium+Pharmaceuticals%2C+Inc.+%28ANTM%29+Shareholders%3A+Grabar+Law+Investigates+Claims+on+Your+Behalf/24567689.html <p>Philadelphia, Pennsylvania--(Newsfile Corp. - March 28, 2025) - Grabar Law Office is investigating whether the Board of Directors of Actinium Pharmaceuticals, Inc. (NYSE: ANTM) breached their fiduciary duties owed to the Company.</p><p><b>Current Actinium Pharmaceuticals, Inc. (NYSE: ANTM)</b> <b>shareholders who have held the stock since on or before October 31, 2022, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them.</b> <b>Learn more or join at: </b><a href="https://grabarlaw.com/the-latest/actinium-shareholder-investigations/">https://grabarlaw.com/the-latest/actinium-shareholder-investigations/</a>. <b>Contact Joshua H. Grabar at </b><a href="mailto:jgrabar@grabarlaw.com"><b>jgrabar@grabarlaw.com</b></a><u><b>,</b></u><b> or call 267-507-6085</b>. </p><p><b>WHY:</b> An underlying securities fraud class http://www.streetinsider.com/Press+Releases/Notice+to+Long-term+Actinium+Pharmaceuticals%2C+Inc.+%28ANTM%29+Shareholders%3A+Grabar+Law+Investigates+Claims+on+Your+Behalf/24567689.html Fri, 28 Mar 2025 17:24:00 -0400 ANTM http://www.streetinsider.com/Newsfile/Notice+to+Long-term+Actinium+Pharmaceuticals%2C+Inc.+%28ANTM%29+Shareholders%3A+Grabar+Law+Investigates+Claims+on+Your+Behalf/24567689.html <p>Philadelphia, Pennsylvania--(Newsfile Corp. - March 28, 2025) - Grabar Law Office is investigating whether the Board of Directors of Actinium Pharmaceuticals, Inc. (NYSE: ANTM) breached their fiduciary duties owed to the Company.</p><p><b>Current Actinium Pharmaceuticals, Inc. (NYSE: ANTM)</b> <b>shareholders who have held the stock since on or before October 31, 2022, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them.</b> <b>Learn more or join at: </b><a href="https://grabarlaw.com/the-latest/actinium-shareholder-investigations/">https://grabarlaw.com/the-latest/actinium-shareholder-investigations/</a>. <b>Contact Joshua H. Grabar at </b><a href="mailto:jgrabar@grabarlaw.com"><b>jgrabar@grabarlaw.com</b></a><u><b>,</b></u><b> or call 267-507-6085</b>. </p><p><b>WHY:</b> An underlying securities fraud class http://www.streetinsider.com/Newsfile/Notice+to+Long-term+Actinium+Pharmaceuticals%2C+Inc.+%28ANTM%29+Shareholders%3A+Grabar+Law+Investigates+Claims+on+Your+Behalf/24567689.html Fri, 28 Mar 2025 17:24:00 -0400 ANTM http://www.streetinsider.com/New+Coverage/Cantor+Fitzgerald+Starts+Amentum+%28AMTM%29+at++Neutral+%28correction%29/24309807.html <p>Cantor Fitzgerald analyst Colin Canfield initiates coverage on Amentum (NYSE: AMTM) with a Neutral rating and a price target of $25.00.</p><p>For an analyst ratings summary and ratings history on Anthem <a href="http://www.streetinsider.com/rating_history.php?q=ANTM">click here</a>. For more ratings news on Anthem <a href="http://www.streetinsider.com/stock_lookup_news.php?q=ANTM&amp;type=analyst">click here</a>.</p><p>Shares of Anthem closed at $482.58 yesterday.</p> http://www.streetinsider.com/New+Coverage/Cantor+Fitzgerald+Starts+Amentum+%28AMTM%29+at++Neutral+%28correction%29/24309807.html Thu, 06 Feb 2025 16:17:05 -0400 AMTM http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Elevance+Health%2C+Inc.+++++For%3A+Jun+27/20268164.html si-local-file:///var/storage/secattach/20220628/20268164.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Elevance+Health%2C+Inc.+++++For%3A+Jun+27/20268164.html Tue, 28 Jun 2022 16:32:00 -0400 ANTM http://www.streetinsider.com/SEC+Filings/Form++11-K+++++++Anthem%2C+Inc.++++++++++++++For%3A+Dec+31/20253696.html si-local-file:///var/storage/secattach/20220624/20253696.html http://www.streetinsider.com/SEC+Filings/Form++11-K+++++++Anthem%2C+Inc.++++++++++++++For%3A+Dec+31/20253696.html Fri, 24 Jun 2022 13:39:00 -0400 ANTM http://www.streetinsider.com/Hot+List/Cigna+%28CI%29+Upgraded%2C+Anthem+%28ANTM%29+Downgraded+by+Morgan+Stanley+on+Biosimilar+Humira+Opportunity/20242687.html si-local-file:///var/storage/newsbody/2022/0622/20242687.html http://www.streetinsider.com/Hot+List/Cigna+%28CI%29+Upgraded%2C+Anthem+%28ANTM%29+Downgraded+by+Morgan+Stanley+on+Biosimilar+Humira+Opportunity/20242687.html Wed, 22 Jun 2022 13:40:39 -0400 ANTM CI http://www.streetinsider.com/Hot+List/Cigna+%28CI%29+Upgraded%2C+Anthem+%28ANTM%29+Downgraded+by+Morgan+Stanley+on+Biosimilar+Humira+Opportunity/20242687.html si-local-file:///var/storage/newsbody/2022/0622/20242687.html http://www.streetinsider.com/Hot+List/Cigna+%28CI%29+Upgraded%2C+Anthem+%28ANTM%29+Downgraded+by+Morgan+Stanley+on+Biosimilar+Humira+Opportunity/20242687.html Wed, 22 Jun 2022 13:40:39 -0400 ANTM CI http://www.streetinsider.com/Downgrades/Cigna+%28CI%29+Upgraded%2C+Anthem+%28ANTM%29+Downgraded+by+Morgan+Stanley+on+Biosimilar+Humira+Opportunity/20242687.html si-local-file:///var/storage/newsbody/2022/0622/20242687.html http://www.streetinsider.com/Downgrades/Cigna+%28CI%29+Upgraded%2C+Anthem+%28ANTM%29+Downgraded+by+Morgan+Stanley+on+Biosimilar+Humira+Opportunity/20242687.html Wed, 22 Jun 2022 13:40:39 -0400 ANTM CI http://www.streetinsider.com/Downgrades/Cigna+%28CI%29+Upgraded%2C+Anthem+%28ANTM%29+Downgraded+by+Morgan+Stanley+on+Biosimilar+Humira+Opportunity/20242687.html si-local-file:///var/storage/newsbody/2022/0622/20242687.html http://www.streetinsider.com/Downgrades/Cigna+%28CI%29+Upgraded%2C+Anthem+%28ANTM%29+Downgraded+by+Morgan+Stanley+on+Biosimilar+Humira+Opportunity/20242687.html Wed, 22 Jun 2022 13:40:39 -0400 ANTM CI http://www.streetinsider.com/Upgrades/Cigna+%28CI%29+Upgraded%2C+Anthem+%28ANTM%29+Downgraded+by+Morgan+Stanley+on+Biosimilar+Humira+Opportunity/20242687.html si-local-file:///var/storage/newsbody/2022/0622/20242687.html http://www.streetinsider.com/Upgrades/Cigna+%28CI%29+Upgraded%2C+Anthem+%28ANTM%29+Downgraded+by+Morgan+Stanley+on+Biosimilar+Humira+Opportunity/20242687.html Wed, 22 Jun 2022 13:40:39 -0400 ANTM CI http://www.streetinsider.com/Upgrades/Cigna+%28CI%29+Upgraded%2C+Anthem+%28ANTM%29+Downgraded+by+Morgan+Stanley+on+Biosimilar+Humira+Opportunity/20242687.html si-local-file:///var/storage/newsbody/2022/0622/20242687.html http://www.streetinsider.com/Upgrades/Cigna+%28CI%29+Upgraded%2C+Anthem+%28ANTM%29+Downgraded+by+Morgan+Stanley+on+Biosimilar+Humira+Opportunity/20242687.html Wed, 22 Jun 2022 13:40:39 -0400 ANTM CI http://www.streetinsider.com/Analyst+Comments/Cigna+%28CI%29+Upgraded%2C+Anthem+%28ANTM%29+Downgraded+by+Morgan+Stanley+on+Biosimilar+Humira+Opportunity/20242687.html si-local-file:///var/storage/newsbody/2022/0622/20242687.html http://www.streetinsider.com/Analyst+Comments/Cigna+%28CI%29+Upgraded%2C+Anthem+%28ANTM%29+Downgraded+by+Morgan+Stanley+on+Biosimilar+Humira+Opportunity/20242687.html Wed, 22 Jun 2022 13:40:39 -0400 ANTM CI http://www.streetinsider.com/Analyst+Comments/Cigna+%28CI%29+Upgraded%2C+Anthem+%28ANTM%29+Downgraded+by+Morgan+Stanley+on+Biosimilar+Humira+Opportunity/20242687.html si-local-file:///var/storage/newsbody/2022/0622/20242687.html http://www.streetinsider.com/Analyst+Comments/Cigna+%28CI%29+Upgraded%2C+Anthem+%28ANTM%29+Downgraded+by+Morgan+Stanley+on+Biosimilar+Humira+Opportunity/20242687.html Wed, 22 Jun 2022 13:40:39 -0400 ANTM CI http://www.streetinsider.com/Analyst+PT+Change/UPDATE%3A+Morgan+Stanley+Downgrades+Anthem+%28ANTM%29+to+Equalweight/20239614.html si-local-file:///var/storage/newsbody/2022/0622/20239614.html http://www.streetinsider.com/Analyst+PT+Change/UPDATE%3A+Morgan+Stanley+Downgrades+Anthem+%28ANTM%29+to+Equalweight/20239614.html Wed, 22 Jun 2022 05:14:57 -0400 ANTM http://www.streetinsider.com/Downgrades/UPDATE%3A+Morgan+Stanley+Downgrades+Anthem+%28ANTM%29+to+Equalweight/20239614.html si-local-file:///var/storage/newsbody/2022/0622/20239614.html http://www.streetinsider.com/Downgrades/UPDATE%3A+Morgan+Stanley+Downgrades+Anthem+%28ANTM%29+to+Equalweight/20239614.html Wed, 22 Jun 2022 05:14:57 -0400 ANTM http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Morgan+Stanley+Downgrades+Anthem+%28ANTM%29+to+Equalweight/20239614.html si-local-file:///var/storage/newsbody/2022/0622/20239614.html http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Morgan+Stanley+Downgrades+Anthem+%28ANTM%29+to+Equalweight/20239614.html Wed, 22 Jun 2022 05:14:57 -0400 ANTM http://www.streetinsider.com/New+Coverage/UPDATE%3A+Loop+Capital+Starts+Anthem+%28ANTM%29+at+Buy/20224543.html si-local-file:///var/storage/newsbody/2022/0616/20224543.html http://www.streetinsider.com/New+Coverage/UPDATE%3A+Loop+Capital+Starts+Anthem+%28ANTM%29+at+Buy/20224543.html Thu, 16 Jun 2022 16:32:48 -0400 ANTM http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Loop+Capital+Starts+Anthem+%28ANTM%29+at+Buy/20224543.html si-local-file:///var/storage/newsbody/2022/0616/20224543.html http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Loop+Capital+Starts+Anthem+%28ANTM%29+at+Buy/20224543.html Thu, 16 Jun 2022 16:32:48 -0400 ANTM http://www.streetinsider.com/Press+Releases/Anthem+Announces+Subsidiary+Brands+Under+Elevance+Health/20217304.html si-local-file:///var/storage/newsbody/2022/0615/20217304.html http://www.streetinsider.com/Press+Releases/Anthem+Announces+Subsidiary+Brands+Under+Elevance+Health/20217304.html Wed, 15 Jun 2022 10:00:00 -0400 A.23804236 ANTM O.01270029 O.01767933 http://www.streetinsider.com/Press+Releases/Anthem+Announces+Subsidiary+Brands+Under+Elevance+Health/20217304.html si-local-file:///var/storage/newsbody/2022/0615/20217304.html http://www.streetinsider.com/Press+Releases/Anthem+Announces+Subsidiary+Brands+Under+Elevance+Health/20217304.html Wed, 15 Jun 2022 10:00:00 -0400 A.23804236 ANTM O.01270029 O.01767933 http://www.streetinsider.com/Press+Releases/Anthem+Announces+Subsidiary+Brands+Under+Elevance+Health/20217304.html si-local-file:///var/storage/newsbody/2022/0615/20217304.html http://www.streetinsider.com/Press+Releases/Anthem+Announces+Subsidiary+Brands+Under+Elevance+Health/20217304.html Wed, 15 Jun 2022 10:00:00 -0400 A.23804236 ANTM O.01270029 O.01767933 http://www.streetinsider.com/Press+Releases/Anthem+Announces+Subsidiary+Brands+Under+Elevance+Health/20217304.html si-local-file:///var/storage/newsbody/2022/0615/20217304.html http://www.streetinsider.com/Press+Releases/Anthem+Announces+Subsidiary+Brands+Under+Elevance+Health/20217304.html Wed, 15 Jun 2022 10:00:00 -0400 A.23804236 ANTM O.01270029 O.01767933 http://www.streetinsider.com/Business+Wire/Anthem+Announces+Subsidiary+Brands+Under+Elevance+Health/20217304.html si-local-file:///var/storage/newsbody/2022/0615/20217304.html http://www.streetinsider.com/Business+Wire/Anthem+Announces+Subsidiary+Brands+Under+Elevance+Health/20217304.html Wed, 15 Jun 2022 10:00:00 -0400 A.23804236 ANTM O.01270029 O.01767933 http://www.streetinsider.com/Business+Wire/Anthem+Announces+Subsidiary+Brands+Under+Elevance+Health/20217304.html si-local-file:///var/storage/newsbody/2022/0615/20217304.html http://www.streetinsider.com/Business+Wire/Anthem+Announces+Subsidiary+Brands+Under+Elevance+Health/20217304.html Wed, 15 Jun 2022 10:00:00 -0400 A.23804236 ANTM O.01270029 O.01767933 http://www.streetinsider.com/Business+Wire/Anthem+Announces+Subsidiary+Brands+Under+Elevance+Health/20217304.html si-local-file:///var/storage/newsbody/2022/0615/20217304.html http://www.streetinsider.com/Business+Wire/Anthem+Announces+Subsidiary+Brands+Under+Elevance+Health/20217304.html Wed, 15 Jun 2022 10:00:00 -0400 A.23804236 ANTM O.01270029 O.01767933